Squarepoint’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
BGI
Squarepoint's NRXP Position: Q3 2026 in Review
Squarepoint sold out of NRX Pharmaceuticals (NRXP) in Q3 2026, closing a stake of 13,166 shares — an estimated $53.8K sold.
Squarepoint first reported a position in NRXP in Q4 2021 and held it in 4 quarters. The position peaked at $141K in Q4 2021. 50 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.
- Squarepoint reported no remaining NRX Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Squarepoint sold 13,166 NRX Pharmaceuticals shares in Q3 2026, an estimated $53.8K.
- Squarepoint first reported a position in NRX Pharmaceuticals in Q4 2021 and held it in 4 quarters.
- Squarepoint's NRX Pharmaceuticals position peaked at $141K in Q4 2021.
- 50 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.